ResMed | RMD - Ordinary Share Capital


ResMed reported $190.83M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Ansell USD 142.94M 885.26M Dec/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.79M 91K Dec/2025
Baxter International USD 516.45M 2.17M Mar/2026
Cochlear AUD 65.4M 1.12B Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Fisher Paykel Healthcare NZD 587.25M 1.35M Dec/2025
Globus Medical USD 135.06M 449K Dec/2025
Haemonetics USD 46.83M 82K Dec/2025
Idexx Laboratories USD 79.24M 611K Mar/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Philips EUR 952.02M 729K Mar/2026
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Steris USD 98.07M 72K Mar/2026
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026